Zimmer, P., Oberste, M., Bloch, W., Schenk, A., Joisten, N., Hartig, P., Wolf, F., Baumann, F. T., Garthe, A., Hallek, M. and Elter, T. (2016). Impact of aerobic exercise training during chemotherapy on cancer related cognitive impairments in patients suffering from acute myeloid leukemia or myelodysplastic syndrome - Study protocol of a randomized placebo-controlled trial. Contemp. Clin. Trials, 49. S. 1 - 6. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1559-2030

Full text not available from this repository.

Abstract

Cancer related cognitive impairments (CRCI) are frequently reported by patients prior to, during and after medical treatment. Although this cognitive decline severely affects patients' quality of life, little is known about effective treatments. Exercise programs represent a promising supportive strategy in this field. However, evidence is sparse and existing studies display methodological limitations. In the planned study, 83 men and women newly diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) will be randomized into one of three treatment groups. During 4 weeks of induction chemotherapy with Anthracycline and Cytarabin patients allocated to exercise group will cycle 3 x/week for 30 min at moderate to vigorous intensity on an ergometer. Patients allocated to placebo group will receive a supervised myofascial release training (3x/week, approx. 30 min) and patients at control group will get usual care. As primary endpoints a cognitive test battery will be conducted measuring performances depending on verbal/spatial memory and executive functioning. Secondary endpoints will be self-perceived cognitive functioning, as well as neurotrophic and inflammatory serum markers. All assessments will be conducted immediately after hospitalization and before chemotherapy is commenced, immediately before discharge of hospital after 45 weeks as well as before continuing medical treatment 3-4 weeks after discharge. This will be the first study investigating the impact of an aerobic exercise training on CRCI in AML/MDS patients. We hope that the study design and the state-of-the-art assessments will help to increase knowledge about CRCI in general and exercise as potential treatment option in this under investigated population. (C) 2016 Elsevier Inc All rights reserved.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Zimmer, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Oberste, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bloch, W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schenk, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Joisten, N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hartig, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wolf, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Baumann, F. T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Garthe, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hallek, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Elter, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-271361
DOI: 10.1016/j.cct.2016.05.007
Journal or Publication Title: Contemp. Clin. Trials
Volume: 49
Page Range: S. 1 - 6
Date: 2016
Publisher: ELSEVIER SCIENCE INC
Place of Publication: NEW YORK
ISSN: 1559-2030
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
HIPPOCAMPAL NEUROGENESIS; PHYSICAL-ACTIVITY; BREAST-CANCER; MANAGEMENT; IRRADIATION; INSTRUMENT; RISKMultiple languages
Medicine, Research & Experimental; Pharmacology & PharmacyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/27136

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item